Pura Vida Investments’s Akoya BioSciences AKYA Stock Holding History

Pura Vida Investments’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-360,789	Closed	-$2.67M	–	86
2023 Q2	$2.67M	Buy	+360,789	New	+$2.41M	0.35%	58
2022 Q4	–	Sell	-147,500	Closed	-$1.73M	–	196
2022 Q3	$1.73M	Buy	+147,500	New	+$1.94M	0.1%	142
2021 Q3	–	Sell	-239,566	Closed	-$4.63M	–	279
2021 Q2	$4.63M	Buy	+239,566	New	+$4.95M	0.14%	123

Other funds holding AKYA

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Pura Vida Investments's AKYA Position: Q3 2023 in Review

Pura Vida Investments sold out of Akoya BioSciences (AKYA) in Q3 2023, closing a stake of 360,789 shares — an estimated $2.67M sold.

Pura Vida Investments first reported a position in AKYA in Q2 2021 and held it in 3 quarters. The position peaked at $4.63M in Q2 2021. 62 funds tracked by Wall St. Rank hold AKYA as of Q3 2023.

Pura Vida Investments reported no remaining Akoya BioSciences position as of Q3 2023 after selling out during the quarter.
Pura Vida Investments sold 360,789 Akoya BioSciences shares in Q3 2023, an estimated $2.67M.
Pura Vida Investments first reported a position in Akoya BioSciences in Q2 2021 and held it in 3 quarters.
Pura Vida Investments's Akoya BioSciences position peaked at $4.63M in Q2 2021.
62 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2023.

Based on Pura Vida Investments's 13F filing for Q3 2023, filed 14 Nov 2023.